PBYI Stock Performance, Insider Transaction and News

PBYI - Puma Biotechnology Inc

Market Cap	168.61M	P/E	32.82	EPS this Y	-46.70%	Ern Qtrly Grth	-
Income	15.38M	Forward P/E	18.05	EPS next Y	-	50D Avg Chg	6.00%
Sales	226.63M	PEG	0.07	EPS past 5Y	-	200D Avg Chg	3.00%
Dividend	N/A	Price/Book	6.52	EPS next 5Y	232.50%	52W High Chg	-30.00%
Recommedations	3.00	Quick Ratio	1.34	Shares Outstanding	48.24M	52W Low Chg	74.00%
Insider Own	15.58%	ROA	8.10%	Shares Float	31.85M	Beta	1.07
Inst Own	68.21%	ROE	40.02%	Shares Shorted/Prior	3.80M/2.70M	Price	3.61
Gross Margin	73.44%	Profit Margin	6.78%	Avg. Volume	216,567	Target Price	4.33
Oper. Margin	-5.25%	Earnings Date	Aug 1	Volume	122,028	Change	1.69%

Healthcare | Biotechnology | United States

About Puma Biotechnology Inc

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Puma Biotechnology Inc News

07/23/24	Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
07/18/24	Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
07/02/24	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06/03/24	Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
06/02/24	Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
05/28/24	Puma Biotechnology to Join Russell 3000 Index
07:36 AM	With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
05/24/24	Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
05/23/24	Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
05/20/24	Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options
05/05/24	Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
05/04/24	Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
05/03/24	Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
05/03/24	Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
05/03/24	Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
05/02/24	Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
05/02/24	Puma Biotechnology Reports First Quarter Financial Results
04/29/24	Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
10:40 AM	What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
04/18/24	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

PBYI Chatroom

Jonnyking Posted - 12 hours ago

$PBYI again, sold 2k shares at 4, will buy back around 3.69 sometime next week, just for fun

TotiG Posted - 1 day ago

$PBYI Does anyone have an idea about the time frame until the judge’s decision? Thanks.

Jonnyking Posted - 1 day ago

$PBYI 2% revenue of Tagrisso as royalty would be great enough, 15% would be dream come true... but quite understandable... Tagrisso is basically eating PBYI's lunch anyway

US_Bull Posted - 1 day ago

$PBYI 5% more and I am in the green this is about to explode

biovalidator Posted - 1 day ago

$PBYI let's go to 20.69

Gius_me Posted - 2 days ago

$PBYI new update but no final decision yet https://www.pacermonitor.com/public/case/41952675/Puma_Biotechnology,_Inc_v_AstraZeneca_Pharmaceuticals_LP_et_al

Bazzil Posted - 4 days ago

$PBYI is this a sympathy play for $JAGX? Trial results expected tomorrow - crofelemer for prophylaxis of diarrhea in adult cancer patients

Gator5326 Posted - 4 days ago

$PBYI

Jonnyking Posted - 1 week ago

$PBYI bought 2k shares back at 3.56, might go lower considering the short interest increased significantly over the past month... who cares, cashed another 600, thanks short sellers... remain the same amount shares with boring day trade... Daddy Alan, do the deal, 1b, 2b, or even 800m...

insiderbuyingselling Posted - 1 week ago

$PBYI new insider selling: 2598 shares. http://insiderbuyingselling.com/?t=PBYI

Stock_Titan Posted - 1 week ago

$PBYI Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results https://www.stocktitan.net/news/PBYI/puma-biotechnology-to-host-conference-call-to-discuss-second-quarter-kuvlgw8ep9eq.html

PenkeTrading Posted - 1 week ago

I found you a Bearish Engulfing Candle Pattern on the daily chart of Puma Biotechnology Inc. $PBYI #PBYI #bearish #nasdaq #tradingsignals #technicalanalysis

Jonnyking Posted - 1 week ago

$PBYI sold 2000 shares at 3.86, will buy back at 3.5 tomorrow if we get there

Kebo07 Posted - 1 week ago

$PBYI when news? I like quiet boards and low followers. Means nobody knows and those are the stocks that usually go bang!

Awesom69Trade Posted - 1 week ago

$PBYI dang! Would have been a nice flip if I sold over $4! It’s all good. Give is some good news Alan!!

Jonnyking Posted - 1 week ago

$PBYI sold 2000 shares at 4.04, bought back at 3.69+0.01=3.7 cashed 600 dollars, thanks shorts

Awesom69Trade Posted - 1 week ago

$PBYI release the kraken!!!

Gius_me Posted - 1 week ago

$PBYI https://www.pacermonitor.com/public/case/41952675/Puma_Biotechnology,_Inc_v_AstraZeneca_Pharmaceuticals_LP_et_al

Awesom69Trade Posted - 1 week ago

$PBYI is that ah volumes legit? Up 6% to $4.22 on 14k volumes. Short covered ah or they know something up tomorrow? I am getting giggity giggity!

Awesom69Trade Posted - 1 week ago

$PBYI tomorrow we going to push over $5.69! Give us $30.69 or $69.69 so we all go to the sphere in Vegas to party in my cybertruck!! Jmo

Jonnyking Posted - 1 week ago

$PBYI close a few puts I sold and some calls I bought last week for about 1k gain, keep core shares... still wishing for that 2% royalty from the judge

CrytpoConverter Posted - 1 week ago

$PBYI 4+ close today, perfect 🍻🤘🤘🤘💥

Awesom69Trade Posted - 1 week ago

$PBYI More volumes to bring in short squeeze and go parabolic. I want my double digits!!

Gius_me Posted - 1 week ago

$PBYI last update July 9th…what he is waiting for ruling the final verdict 😱🙈☹️😭

Edyy88 Posted - 1 week ago

$PBYI Hi. I'm looking for good investment, what's happening here? I saw som comment about lawsuit? What kind of catalyst are here? Thank you 😊

Jonnyking Posted - 1 week ago

$PBYI 2% of Tagrisso's revenue is all I am asking. 5% would be awesome, 10% would be dream coming true............ 20% would be...impossible but, thank you

kman1221 Posted - 2 weeks ago

$PBYI is this bump the bio tech market rally or is it us ? We will know on Monday ..

Awesom69Trade Posted - 2 weeks ago

$PBYI Two big green day! I am getting excited into the weekend. Next week we can pop big with any good news or steady run over $5.69. Make us rich daddy Alan!!!

Jonnyking Posted - 2 weeks ago

$PBYI all we need is 2% of Tagrisso's revenue till patent expiration. Tagrisso will continue sell till about 100b, we only need 800m, fare enough... or buy us at 1.3b-1.5b

Jonnyking Posted - 2 weeks ago

$PBYI might end the day as red, typical short sellers trading on PBYI, we need judge's number or settlement news

Analyst Ratings

HC Wainwright & Co.	Buy	Jul 26, 24
HC Wainwright & Co.	Buy	Jun 4, 24
HC Wainwright & Co.	Buy	Jun 3, 24
HC Wainwright & Co.	Buy	May 20, 24
HC Wainwright & Co.	Buy	May 3, 24
HC Wainwright & Co.	Buy	Mar 1, 24
HC Wainwright & Co.	Buy	Feb 13, 24
HC Wainwright & Co.	Buy	Sep 20, 23
HC Wainwright & Co.	Buy	Aug 4, 23

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Wong Alvin F	Chief Scientific Off.. Chief Scientific Officer	Dec 04	Sell	3.7608	280	1,053	97,934	01/10/24
Wong Alvin F	Chief Scientific Off.. Chief Scientific Officer	Jan 03	Sell	4.4859	7,733	34,689	98,214	01/05/24
Ludwig Jeffrey Jerome	Chief Commercial Off.. Chief Commercial Officer	Jan 03	Sell	4.4859	12,956	58,119	99,970	01/05/24
AUERBACH ALAN H	President and CEO President and CEO	Jan 03	Sell	4.4859	41,396	185,698	6,936,947	01/05/24
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Jan 03	Sell	4.4859	15,682	70,348	128,666	01/05/24
HUNT DOUGLAS M	See Remarks See Remarks	Jan 03	Sell	4.4859	8,358	37,493	103,319	01/05/24
Wong Alvin F	Chief Scientific Off.. Chief Scientific Officer	Jul 03	Sell	3.3112	6,938	22,973	105,947	07/06/23
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Jul 03	Sell	3.3112	14,680	48,608	144,348	07/06/23
Ludwig Jeffrey Jerome	Chief Commercial Off.. Chief Commercial Officer	Jul 03	Sell	3.3112	12,103	40,075	112,926	07/06/23
HUNT DOUGLAS M	See Remarks See Remarks	Jul 03	Sell	3.3112	7,809	25,857	111,677	07/06/23
AUERBACH ALAN H	President and CEO President and CEO	Jul 03	Sell	3.3112	60,698	200,983	6,978,343	07/06/23
WILSON TROY EDWARD	Director Director	Jun 13	Sell	3.45	27,000	93,150	350	06/15/23
MOYES JAY M	Director Director	Jun 13	Sell	3.45	22,000	75,900	16,322	06/15/23
Stuglik Brian M	Director Director	Jun 13	Sell	3.46	9,900	34,254	31,958	06/15/23
Senderowicz Adrian	Director Director	Jun 13	Sell	3.45	27,000	93,150		06/15/23
Dorval Allison	Director Director	Jun 13	Sell	3.45	10,000	34,500	17,000	06/15/23
MILLER MICHAEL PATRICK	Director Director	Jun 13	Sell	3.45	13,500	46,575	41,358	06/15/23
AUERBACH ALAN H	President and CEO President and CEO	Jan 03	Sell	4.1779	27,241	113,810	6,852,638	01/05/23
AUERBACH ALAN H	President and CEO President and CEO	Dec 02	Sell	4.49780	1,251	5,627	6,311,698	12/06/22
HUNT DOUGLAS M	See Remarks See Remarks	Dec 02	Sell	4.49780	429	1,930	75,575	12/06/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Dec 02	Sell	4.49780	159	715	110,926	12/06/22
Wong Alvin F	Chief Scientific Off.. Chief Scientific Officer	Dec 02	Sell	4.49780	514	2,312	58,013	12/06/22
HUNT DOUGLAS M	See Remarks See Remarks	Nov 02	Sell	2.25	429	965	76,004	11/04/22
AUERBACH ALAN H	President and CEO President and CEO	Nov 02	Sell	2.25	1,242	2,794	6,312,949	11/04/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Nov 02	Sell	2.25	163	367	111,085	11/04/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Oct 03	Sell	2.3354	165	385	111,248	10/05/22
HUNT DOUGLAS M	See Remarks See Remarks	Oct 03	Sell	2.3354	435	1,016	76,433	10/05/22
AUERBACH ALAN H	President and CEO President and CEO	Oct 03	Sell	2.3354	1,260	2,943	6,314,191	10/05/22
MILLER MICHAEL PATRICK	Director Director	Aug 09	Sell	3.5517	25,000	88,792	54,858	08/10/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Aug 02	Sell	2.89	161	465	111,577	08/04/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Jul 05	Sell	2.6315	9,328	24,547	111,738	08/04/22
HUNT DOUGLAS M	See Remarks See Remarks	Aug 02	Sell	2.89	429	1,240	77,301	08/04/22
AUERBACH ALAN H	President and CEO President and CEO	Aug 02	Sell	2.89	1,247	3,604	6,316,705	08/04/22
HUNT DOUGLAS M	See Remarks See Remarks	Jul 05	Sell	2.6315	3,753	9,876	77,730	07/07/22
AUERBACH ALAN H	President and CEO President and CEO	Jul 05	Sell	2.6315	26,140	68,787	6,317,952	07/07/22
Ludwig Jeffrey Jerome	Chief Commercial Off.. Chief Commercial Officer	Jul 05	Sell	2.6315	5,835	15,355	64,625	07/07/22
Wong Alvin F	Chief Scientific Off.. Chief Scientific Officer	Jul 05	Sell	2.6315	2,920	7,684	58,527	07/07/22
Senderowicz Adrian	Director Director	Jun 16	Sell	2.6313	27,858	73,303	27,000	06/21/22
WILSON TROY EDWARD	Director Director	Jun 16	Sell	2.5835	27,858	71,971	27,350	06/21/22
Stuglik Brian M	Director Director	Jun 16	Sell	2.686	13,000	34,918	41,858	06/21/22
MOYES JAY M	Director Director	Jun 16	Sell	2.6411	22,858	60,370	38,322	06/21/22
Wong Alvin F	Chief Scientific Off.. Chief Scientific Officer	Jun 02	Sell	1.9241	587	1,129	61,447	06/06/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Jun 02	Sell	1.9218	162	311	121,066	06/06/22
HUNT DOUGLAS M	See Remarks See Remarks	Jun 02	Sell	1.9441	417	811	81,483	06/06/22
AUERBACH ALAN H	President and CEO President and CEO	Jun 02	Sell	1.9441	1,200	2,333	6,344,092	06/06/22
HUNT DOUGLAS M	See Remarks See Remarks	May 03	Sell	2.3101	438	1,012	81,900	05/05/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	May 03	Sell	2.3401	165	386	121,228	05/04/22
AUERBACH ALAN H	President and CEO President and CEO	May 03	Sell	2.3201	1,263	2,930	6,345,292	05/04/22
AUERBACH ALAN H	President and CEO President and CEO	Apr 04	Sell	3.078	1,198	3,687	6,346,555	04/05/22
NOUGUES MAXIMO F	Chief Financial Offi.. Chief Financial Officer	Apr 04	Sell	3.078	206	634	121,393	04/05/22